Glycolipid Disialoganglioside-directed Antibody Interactions [MoA] - N0000191499

Pharmacologic Class Information

Pharmacologic Code N0000191499
Pharmacologic Name Glycolipid Disialoganglioside-directed Antibody Interactions
Pharmacologic Uses
  • GD2-binding monoclonal antibody
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Glycolipid Disialoganglioside-directed Antibody Interactions

The following table contains 2 products whose active ingredient are classified under the same pharmacologic class Glycolipid Disialoganglioside-directed Antibody Interactions [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
66302-014Unituxin Non-Proprietary Name: DinutuximabInjectionIntravenousUnited Therapeutics CorporationACTIVE
73042-201Danyelza Non-Proprietary Name: NaxitamabInjectionIntravenousY-mabs Therapeutics, Inc.ACTIVE